Physician profile
Gavin Lynch
NPI 1184203895
$2,046.59
in general payments reported to CMS, 2019-2025
7 companies · $192 in 2025
The $192 reported for 2025 was more than what 82% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,855 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,075 · Food and Beverage: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,074.70 |
| Food and Beverage | $971.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,748.56 | 2024 | |
| La Jolla Pharmaceutical Company | $94.07 | 2024-2025 | Giapreza |
| Abiomed | $79.79 | 2024-2025 | Impella |
| Haemonetics Corporation | $62.82 | 2025 | Teg6s Hemostasis System |
| Grifols USA, LLC | $23.54 | 2025 | Thrombate III |
| Astrazeneca Pharmaceuticals LP | $19.69 | 2024 | Andexxa |
| Atricure, INC. | $18.12 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.